Revisiting Flubendazole Through Nanocrystal Technology: Statistical Design, Characterization and Its Potential Inhibitory Effect on Xenografted Lung Tumor Progression in Mice.

MLA

de Souza Gonçalves, Débora, et al. “Revisiting Flubendazole Through Nanocrystal Technology: Statistical Design, Characterization and Its Potential Inhibitory Effect on Xenografted Lung Tumor Progression in Mice.” Journal of Cluster Science, vol. 34, no. 1, Jan. 2023, pp. 261–72. EBSCOhost, https://doi.org/10.1007/s10876-022-02220-x.

APA

de Souza Gonçalves, D., Yukuyama, M. N., Miyagi, M. Y. S., Silva, T. J. V., Lameu, C., Bou-Chacra, N. A., & de Araujo, G. L. B. (2023). Revisiting Flubendazole Through Nanocrystal Technology: Statistical Design, Characterization and Its Potential Inhibitory Effect on Xenografted Lung Tumor Progression in Mice. Journal of Cluster Science, 34(1), 261–272. https://doi.org/10.1007/s10876-022-02220-x

Chicago

de Souza Gonçalves, Débora, Megumi Nishitani Yukuyama, Mariana Yasue Saito Miyagi, Tâmara Juliane Vieira Silva, Claudiana Lameu, Nadia Araci Bou-Chacra, and Gabriel Lima Barros de Araujo. 2023. “Revisiting Flubendazole Through Nanocrystal Technology: Statistical Design, Characterization and Its Potential Inhibitory Effect on Xenografted Lung Tumor Progression in Mice.” Journal of Cluster Science 34 (1): 261–72. doi:10.1007/s10876-022-02220-x.